Chikungunya virus structural and non-structural antigens — Drug Target

All drugs that target Chikungunya virus structural and non-structural antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Inactivated viral vaccine

Phase 3 pipeline (1)

• Biological Vaccine VLA1553 · Valneva Austria GmbH · Inactivated viral vaccine · Immunology / Infectious Disease
  VLA1553 is an inactivated chikungunya virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against chikungunya virus infection.